Restoring invisible and abandoned trials – new podcast episode

Communications / 01 October 2020

Photo by Pau Casals on Unsplash

In the new episode of the Drug Safety Matters podcast, explore the problem of the data we don't see and find out what can be done to peel back the curtain.


Clinical trials are the “gold standard” of evidence-based medicine – the best way we have to test whether a drug is safe and effective before it enters the market. But if trial data is poorly reported or – even worse – left unpublished, how are we supposed to determine the true value of a medical treatment?

Peter Doshi, associate editor at The BMJ and founder of the Restoring Invisible and Abandoned Trials (RIAT) Support Center, has made it his mission to fix the problem and improve data transparency for good.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Learn more

To find out a lot more about Peter Doshi and his work, be sure to visit the RIAT Support Center here.

Peter Doshi on Drug Safety Matters. Photo: UMC

Peter Doshi on Drug Safety Matters. Photo: UMC

Related Articles

Fifty years of putting medicines and vaccine safety at the heart of global healthcare

Catching Black swans – New podcast out now

Patient safety set to gain from new partnership between CDISC and UMC

You may also like

Fifty years of putting medicines and vaccine safety at the heart of global healthcare

The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.

Communications / 11 March 2024

Catching Black swans – New podcast out now

We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.

Communications / 04 March 2024

Patient safety set to gain from new partnership between CDISC and UMC

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

Communications / 20 February 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more